REPLIGEN CLINICAL PARTNERS LP
DEFA14A, 2000-04-04
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: VERMONT PURE HOLDINGS LTD, DEF 14A, 2000-04-04
Next: SPACELABS MEDICAL INC, 4, 2000-04-04





                                 SCHEDULE 14A
                                (RULE 14a-101)
                   INFORMATION REQUIRED IN PROXY STATEMENT
                           SCHEDULE 14A INFORMATION
               PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE
                       SECURITIES EXCHANGE ACT OF 1934

|X|  Filed by the Registrant
|_|  Filed by a Party other than the Registrant

Check the appropriate box:
|_|  Preliminary Proxy Statement
|_|  Confidential, for Use of the Commission Only
            (as permitted by Rule 14a-6(e)(2)
|_|  Definitive proxy statement
|X|  Definitive additional materials
|_|  Soliciting material pursuant to Section 240.14a-11(c) or
            Section 240.14a-12

                       REPLIGEN CLINICAL PARTNERS, L.P.
               (Name of Registrant as Specified In Its Charter)

                       REPLIGEN CLINICAL PARTNERS, L.P.
                  (Name of Person(s) Filing Proxy Statement)

Payment of Filing Fee (Check the appropriate box):
     |X| No fee required.
     |_| Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and
         0-11.
         (1)   Title of each class of securities to which transaction
               applies: Class A Units and Class B Units

         (2)   Aggregate number of securities to which transaction applies:
               712.5 Units of Limited Partnership Interests

         (3)   Per unit price or other underlying value of transaction
               computed pursuant to Exchange Act Rule 0-11:

         (4)   Proposed maximum aggregate value of transaction:

         (5)   Total fee paid:

     |_| Fee paid previously with preliminary materials.
     |_| Check box if any part of the fee is offset as provided by Exchange
         Act Rule 0-11(a)(2) and identify the filing for which the
         offsetting fee was paid previously. Identify the previous filing by
         registration statement number, or the Form or Schedule and the date
         of its filing.
         (1)   Amount Previously Paid:

         (2)   Form, Schedule or Registration Statement No.:

         (3)   Filing Party:

         (4)   Date Filed:






                       REPLIGEN CLINICAL PARTNERS, L.P.
                              117 FOURTH AVENUE
                              NEEDHAM, MA 02194
                                (800) 742-4744




Dear Limited Partner:

As previously described in a Proxy Statement Dated February 15, 2000, a
special meeting of the limited partners was held March 16, 2000. At that time
the meeting was adjourned until May 2, 2000.

All Limited Partners who have not yet submitted their consent cards or
replacement consent cards are encouraged to return their ballots as soon as
possible. Regardless of the number of units you own, it is important that
they are represented and voted. If you have not already mailed your consent
card, please take a moment to sign, date and mail the enclosed duplicate
consent card in the return envelope.

                   Please return your consent card promptly
                         to vote your interest at the
               May 2, 2000 special meeting of limited partners

If you have already voted no further action is needed at this time. If you
have questions, please contact Investor Communication Services at
(800) 742-4744. Thank you for your assistance in this matter.

                                  Sincerely,

                                  REPLIGEN DEVELOPMENT CORPORATION
                                  General Partner

                                  Theodore E. Maione
                                  President


March 16, 2000



FRONT SIDE:



PROXY                                                                   PROXY

                       REPLIGEN CLINICAL PARTNERS, L.P
                     SPECIAL MEETING OF LIMITED PARTNERS

   THIS PROXY IS SOLICITED ON BEHALF OF REPLIGEN CLINICAL PARTNERS, L.P. BY
            REPLIGEN DEVELOPMENT CORPORATION, THE GENERAL PARTNER

The undersigned hereby appoints Theodore E. Maione or his designee with full
power of substitution, the attorney and the proxy of the undersigned, to
represent and to vote, as designated below, all units of limited partnership
interest ("Limited Partnership Interest") of Repligen Clinical Partners,
L.P., a Delaware limited partnership (the "Partnership"), that the
undersigned is entitled to vote if personally present at the Special Meeting
of Limited Partners of Repligen Partners to be held on March, XX, 2000 at
[time], local time, at [location] and at any adjournment(s) or
postponement(s) thereof. This proxy revokes all prior proxies given by the
undersigned.

         The proposals to authorize are:

         1.       Approval for the termination of Repligen Partners.
                           For  |_|        Against  |_|       Abstain  |_|

         2.       In his discretion, the proxy is authorized to vote upon
                  such other business as may properly come before the Special
                  Meeting or any adjournment or postponement thereof.

THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED
HEREIN BY THE UNDERSIGNED LIMITED PARTNER. THE GENERAL PARTNER RECOMMENDS A
VOTE FOR PROPOSALS 1 & 2. IF NO DIRECTION IS MADE ON THIS CARD, THE PROXY
WILL BE VOTED "FOR" PROPOSALS 1 & 2.

                    YOUR SIGNATURE IS REQUIRED ON REVERSE





REVERSE SIDE:


PLEASE MARK, SIGN, DATE AND RETURN THE PROXY PROPERLY USING THE ENCLOSED
PRE-PAID ENVELOPE OR DELIVER TO: Investor Communication Services, 265
Franklin Street, 16th Floor, Boston, MA 02110. If you have any questions,
please call (800) 742-4744. Facsimile copies of the front and reverse sides
of this Proxy, properly completed and duly executed, will be accepted at
(617) 439-8955.

ACCOUNT NUMBER:                     Dated:________________________________

UNITS:                              --------------------------------------
                                    Signature

                                    --------------------------------------
                                    Signature (if held jointly)

                                    --------------------------------------
                                    Title

                                    Please sign exactly as name appears
                                    hereon. When Limited Partnership
                                    Interests are held by joint tenants, both
                                    should sign. When signing as an attorney,
                                    as executor, administrator, trustee or
                                    guardian, please give full title as such.
                                    If a corporation, please sign in name by
                                    President or other authorized officer. If
                                    a partnership, please sign in partnership
                                    name by authorized person.

PLEASE SIGN, MARK, DATE AND RETURN YOUR PROXY CARD TODAY.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission